Valery Brunel

Dr. Valery Brunel

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Hypertension
Verified
Journal Article
Closed access
PDF file
MHMouad Hamzaoui
Mouad Hamzaoui
DGDeborah Groussard
Deborah Groussard
DNDorian Nezam
Dorian Nezam
ZDZoubir Djerada
Zoubir Djerada
GLGaspard Lamy
Gaspard Lamy
DGDominique Guerrot
Dominique Guerrot
Background: Autosomal dominant polycystic kidney disease is the most frequent hereditary kidney disease and is generally due to mutations in PKD1 and PKD2 , encoding polycystins 1 and 2. In autosomal dominant polycystic kidney disease, hypertension and cardiovascular disorders are highly prevalent, but their mechanisms are partially understood. Methods: Since endothelial cells express the polycystin complex, where it plays a central role in the mechanotransduction of blood flow, we generated a murine model with inducible deletion of Pkd1 in endothelial cells ( Cdh5-Cre ERT2 ; Pkd1 fl/fl ) to specifically determine the role of endothelial polycystin-1 in autosomal dominant polycystic kidney disease. Results: Endothelial deletion of Pkd1 induced endothelial dysfunction, as demonstrated by impaired flow-mediated dilatation of resistance arteries and impaired relaxation to acetylcholine, increased blood pressure and prevented the normal development of arteriovenous fistula. In experimental chronic kidney disease induced by subtotal nephrectomy, endothelial deletion of Pkd1 further aggravated endothelial dysfunction, vascular remodeling, and heart hypertrophy. Conclusions: Altogether, this study provides the first in vivo demonstration that specific deletion of Pkd1 in endothelial cells promotes endothelial dysfunction and hypertension, impairs arteriovenous fistula development, and potentiates the cardiovascular alterations associated with chronic kidney disease.

1 January 2016 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
NPNicolas Peschanski
Nicolas Peschanski
CCCamille Chenevier-Gobeaux
Camille Chenevier-Gobeaux
LMLynda Mzabi
Lynda Mzabi
RLRémy Lucas
Rémy Lucas
SOSiham Ouahabi
Siham Ouahabi
PRPatrick Ray
Patrick Ray
An accurate assessment of septic patients at risk for poor clinical outcomes is challenging for clinicians in the emergency department (ED). We aimed to evaluate the prognostic value of procalcitonin (PCT) in septic patients in the ED for predicting death. In a retrospective study, 188 septic patients (median age 63 [IQR 51–80]) of two French university hospitals were included. Patients who deceased within 30 days (20 %, n = 37) presented higher PCT value at admission (median 34.0 µg/L [5.0–71.9]) in comparison with the survivals (median 6.4 µg/L [4.1–13.1], p = 0.0005). ROC curve analysis indicated a moderate AUC of 0.686 [95 % CI 0.613–0.752] and an optimal PCT threshold value at 32.5 [95 % CI 21.8–43.3] µg/L that was associated with a 51 % [34–67] sensitivity, a 96 % [90–98] specificity, a 73 % [52–88] positive predictive value, and a 89 % [83–93] negative predictive value for death. Only 26 patients (14 %) had PCT values above this threshold (19 in the deceased group vs 7 in survival group, p < 0.0001). By multivariate analysis, only three variables remained significantly predictive of the death: personal history of cardiovascular disease (OR 3.1 [1.0–9.4], p = 0.046), the presence of severe sepsis/septic shock in the ER (OR 4.4 [1.3–12.3], p = 0.013), and a PCT level >32.5 µg/L (OR 36.0 [10.0–128.4], p < 0.0001). Similar results were obtained when considering the combined outcome death and/or admission in ICU. Elevated value of PCT at admission has moderate accuracy to identify poor outcome in ED septic patients in daily practice.

15 October 2018 in Biochemia Medica
Verified
Journal Article
Open access
PDF file
ASAurélien Schrapp
Aurélien Schrapp
FFFrançois Fraissinet
François Fraissinet
CHCharles Hervouet
Charles Hervouet
HGHélène Girot
Hélène Girot
VBValery Brunel
Valery Brunel
Biotin and high-sensitivity cardiac troponin T assay

15 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HMHind Messaoudi
Hind Messaoudi
TLThomas Levesque
Thomas Levesque
PPPerzo Nicolas Perzo
Perzo Nicolas Perzo
EBElodie Berg
Elodie Berg
GFGuillaume Feugray
Guillaume Feugray
JBJeremy Bellien
Jeremy Bellien
Introduction. This study addressed the hypothesis that subtotal nephrectomy associated with a high-phosphorus diet (5/6Nx + P) in rats represents a suitable animal model to mimic the cardiovascular consequences of chronic kidney disease (CKD) including calcified aortic valve disease (CAVD). Indeed, the latter contributes to the high morbidity and mortality of CKD patients and sorely lacks preclinical models for pathophysiological and pharmacological studies. Methods. Renal and cardiovascular function and structure were compared between sham-operated and 5/6 Nx rats + P 10 to 12 weeks after surgery. Results. As expected, 11 weeks after surgery, 5/6Nx + P rats developed CKD as demonstrated by their increase in plasma creatinine and urea nitrogen and decrease in glomerular filtration rate, estimated by using fluorescein-isothiocyanate-labelled sinistrin, anemia, polyuria, and polydipsia compared to sham-operated animals on a normal-phosphorus diet. At the vascular level, 5/6Nx + P rats had an increase in the calcium content of the aorta; a decrease in mesenteric artery dilatation in response to a stepwise increase in flow, illustrating the vascular dysfunction; and an increase in blood pressure. Moreover, immunohistology showed a marked deposition of hydroxyapatite crystals in the aortic valve of 5/6Nx + P rats. Echocardiography demonstrated that this was associated with a decrease in aortic valve cusp separation and an increase in aortic valve mean pressure gradient and in peak aortic valve velocity. Left-ventricular diastolic and systolic dysfunction as well as fibrosis were also present in 5/6Nx + P rats. Conclusion. This study demonstrates that 5/6Nx + P recapitulates the cardiovascular consequences observed in humans with CKD. In particular, the initiation of CAVD was shown, highlighting the interest of this animal model to study the mechanisms involved in the development of aortic stenosis and test new therapeutic strategies at an early stage of the disease.

1 September 2011 in The Lancet
Verified
Journal Article
Closed access
VBValery Brunel
Valery Brunel
BCBruno Cauliez
Bruno Cauliez
LLLaurence Lacaze
Laurence Lacaze
GRGhassan Riachi
Ghassan Riachi
GGGilles Gargala
Gilles Gargala
MSMichel Scotté
Michel Scotté

1 February 2018 in Clinical Chemistry
Verified
Journal Article
Closed access
HGHélène Girot
Hélène Girot
MDMarion Déhais
Marion Déhais
FFFrançois Fraissinet
François Fraissinet
JWJulien Wils
Julien Wils
VBValery Brunel
Valery Brunel
A 3-year-old girl with Alagille syndrome and Hashimoto thyroiditis presented with unexpected hyponatremia. She was previously known for hyponatremia associated with edema when hypothyroidism was diagnosed. At clinical examination, no edema was observed. Biological values are shown (Table 1). View this table: Table 1. Blood sample results from lithium heparin tube. …